← back to search

Jochen Metzger

Medizinische Hochschule Hannover · DE
Area of research
Spectroscopy · Surgery
Research interest
Research interests include Medicine, Internal medicine, Transplantation, Gastroenterology, Urine, and Hematopoietic stem cell transplantation.
h-index
citations
513
works
11
NIH funding
primary concept
email

Recent publications

Predictive performance and clinical application of COV50, a urinary proteomic biomarker in early COVID-19 infection: a prospective multicentre cohort study
The Lancet Digital Health 2022cited by 30position: middledoi
A urinary peptidomic profile predicts outcome in SARS-CoV-2-infected patients
EClinicalMedicine 2021cited by 47position: middledoi
Bile and urine peptide marker profiles: access keys to molecular pathways and biological processes in cholangiocarcinoma
Journal of Biomedical Science 2020cited by 37position: middledoi
A multicenter prospective, randomized, placebo-controlled phase II/III trial for preemptive acute graft-versus-host disease therapy
Leukemia 2020cited by 17position: middledoi
A combined bile and urine proteomic test for cholangiocarcinoma diagnosis in patients with biliary strictures of unknown origin
United European Gastroenterology Journal 2017cited by 32position: middledoi
Urine peptidome analysis predicts risk of end-stage renal disease and reveals proteolytic pathways involved in autosomal dominant polycystic kidney disease progression
Nephrology Dialysis Transplantation 2016cited by 35position: middledoi
Proteomics for rejection diagnosis in renal transplant patients: Where are we now?
World Journal of Transplantation 2016cited by 33position: middledoi
The proteome pattern cGvHD_MS14 allows early and accurate prediction of chronic GvHD after allogeneic stem cell transplantation
Leukemia 2016cited by 24position: middledoi
Discovery and validation of urinary biomarkers for detection of renal cell carcinoma
Journal of Proteomics 2013cited by 72position: middledoi
Proteomic peptide profiling for preemptive diagnosis of acute graft-versus-host disease after allogeneic stem cell transplantation
Leukemia 2013cited by 52position: middledoi
Urine proteomic analysis differentiates cholangiocarcinoma from primary sclerosing cholangitis and other benign biliary disorders
Gut 2012cited by 134position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Harald Mischak · Medizinische Hochschule Hannover7 papers (2012–2021)William Mullen · University of Glasgow5 papers (2012–2020)Michael P. Manns · Oslo University Hospital3 papers (2012–2020) · 3 papers (2012–2016)Holger Husi · Medizinische Hochschule Hannover3 papers (2013–2020)Zoya Kuzmina · Center for Cancer Research2 papers (2013–2016)Eva M. Weissinger · Medizinische Hochschule Hannover2 papers (2013–2016)D Ihlenburg-Schwarz · Medizinische Hochschule Hannover2 papers (2013–2016)Martin Pejchinοvski · Thermo Fisher Scientific (Germany)2 papers (2016–2020)J Krauter · Medizinische Hochschule Hannover2 papers (2013–2016)Tim O. Lankisch · Medizinische Hochschule Hannover2 papers (2012–2017)Justyna Siwy · Charité - Universitätsmedizin Berlin2 papers (2016–2021)Torsten Voigtländer · Medizinische Hochschule Hannover2 papers (2017–2020)Arnold Ganser · Radboud University Medical Center2 papers (2013–2016) · 2 papers (2013–2020)Michael Stadler · Illinois State University2 papers (2013–2016) · 2 papers (2016–2021)Hildegard Greinix · Medical College of Wisconsin2 papers (2013–2016)H. Diedrich · Medizinische Hochschule Hannover2 papers (2013–2016)Ernst Holler · Polyclinic Medical Center2 papers (2013–2016)